As France’s CCPA Group celebrates its 60th anniversary in 2026, the animal nutrition company is charting an expansive growth trajectory centered on what leadership calls ‘Enhanced Nutrition’, a comprehensive approach that integrates animal biology, functional ingredients, and digital technology to address mounting challenges in livestock farming. In an interview with Expana at EuroTier 2026, in Hanover, Germany, last week, François Pellet, CEO of CCPA Group, outlined how the company plans to expand through operational footprint expansion and research spending to execute this strategy.
The Enhanced Nutrition concept represents a fundamental shift in how CCPA approaches animal nutrition challenges and, in Pellet’s words, will become the “cornerstone” of the company’s “value proposition.” Pellet emphasized that the strategy rests on three interconnected dimensions. The first focuses on a deeper understanding of animal biology and physiology with practical implications for farmers. The second involves stronger comprehension of the nutritional and functional value of ingredients, examining their functional properties more closely. The third incorporates digital technology and mass data analysis to create real-time dashboards and predictive models that optimize margin over feed cost.
“Nutrition alone is no longer enough to address the growing complexity of livestock farming, economic and environmental challenges, and customers’ expectations,” Pellet said. The company plans to advance this strategy further by incorporating AI to help nutritionists identify deviations and recommend corrective actions.
The company’s commitment to its Enhanced Nutrition strategy extends to significant capital investments across its European footprint. In September 2025, CCPA announced a €3.5 million modernization and expansion program at its Janzé premix plant in France, designed to increase annual production capacity by 20%. The investment, which continued through 2026, includes substantial dosing automation improvements that allow around 50 additional raw materials to be dosed automatically. This technological advancement enables the facility to transition from a three-shift to a two-shift operational model while maintaining increased output.
“The investment will be completed by December 2026. Ramp-up is already underway and in line with our 60,000-ton annual capacity target,” Pellet said. The enhanced capacity supports growth in France, CCPA’s historical market, which remains strategically important. The Janzé plant also serves numerous export markets.
Beyond France, CCPA has pursued strategic expansion through acquisition and new facility development. The company acquired a majority stake in Turkish company Yem-Vit, which generates approximately €15 million in annual revenue and employs about 50 people. The acquisition, completed in June 2026, builds on CCPA’s presence in Turkey, which spans about 15 years and includes the establishment of CCPA Turkey in 2019. “We believe in the long-term growth potential of the Turkish market. We also view Turkey as a hub for the Middle East. That’s one of the reasons for this acquisition,” Pellet said.
According to Pellet, Yem-Vit and CCPA are highly complementary. CCPA Turkey has maintained a historical position in dairy and beef production, primarily serving large farms and distributors. Yem-Vit, conversely, maintains a strong position in poultry, primarily serving feed millers. He said the combined operation covers more animal species, more distribution channels, and virtually all market segments. The acquisition also provides increased market visibility and enhanced resources and capabilities locally, including local laboratory capabilities, to better serve customers. The overall objective is to establish a regional platform in Turkey.
In 2027, CCPA plans significant investments not only in its existing facilities in Spain and Turkey, but also the commissioning of a new premix plant in Portugal. This plant is expected to be completed in 2027 with a targeted 15,000 tons production capacity, Pellet said. It will replace an existing plant that is too small for future needs. It will serve Portugal and CCPA’s African markets.
Research and development capabilities represent another priority for 2027. CCPA plans to increase its R&D budget next year and help expand the Euronutrition research farm in France with a new feed mill for manufacturing experimental diets and two additional poultry houses. The Euronutrition investment is being shared with two other shareholders.
“Investment in R&D will be aligned with our three-dimension strategy: Nutrition, functional ingredients, and digital tools,” Pellet said.
Pellet emphasized that the company’s board strongly supports this long-term vision. “We speak about the next five years, not just the next quarter,” Pellet said, noting that the board prioritizes the long-term benefits of research over short-term immediate performance metrics.
Written by Simon Duke